The nonprofit will act as a liaison between the adrenal insufficiency community and regulators as device makers develop ...
Nanopath raises $25 million to support an FDA 510(k) study and manufacturing scale-up for its point-of-care vaginitis assay.
Early data show eectronic genome mapping detected all abnormalities found by standard cytogenetics in blood cancers.
The FDA has approved Promega’s PCR-based OncoMate MSI Dx Analysis System as a companion diagnostic for Merck’s Keytruda.
The FDA has cleared BD OneFlow LST and B-CLPD T1 tests for B-cell non-Hodgkin lymphoma, including CLL, enabling US ...
The American Cancer Society now recommends routine PSA-based prostate cancer screening, citing stronger evidence for reduced mortality.
Hoag researchers report a blood-based RNA marker that detects serous tubal intraepithelial carcinoma, a precursor to ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results